Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy
- 1 February 1986
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 7 (1), 23-30
- https://doi.org/10.1007/bf01886732
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Weight gain during adjuvant chemotherapy for breast cancerBreast Cancer Research and Treatment, 1985
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- Height, weight, and risk of breast cancer relapseBreast Cancer Research and Treatment, 1985
- CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST CANCERThe Lancet, 1984
- Combined modality approach in breast cancer with isolated or multiple metastasesAmerican Journal of Clinical Oncology, 1984
- AbstractsBreast Cancer Research and Treatment, 1983
- ADJUVANT CHEMOTHERAPY IN BREAST CANCERThe Lancet, 1983
- Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancerAmerican Journal of Clinical Oncology, 1983
- Surgical Adjuvant Chemotherapy in Cancer of the BreastAnnals of Surgery, 1968
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958